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ABSTRACT 
Hypervalent iodine compounds have been known for their remarkable reactivity 
as powerful reagents in the field of organic chemistry.  They present a class of 
compounds that are typically benign when compared to their metal containing 
counterparts and also allow ease of handling. The focus of this research has been to find a 
new way to produce an imide transfer reaction using hypervalent iodine reagents.  Two 
new reagents were discovered during the process and one was chosen as the focus reagent 
for the imide transfer. Optimized conditions were found to produce the functional group 
transfer using the novel mu-oxo type reagent with good yields, which varied depending 
on the starting substrate.  The desired products from the reaction are important because 
some of the compounds have found possible application in the treatment of certain 
diseases.  This research presents an interesting look into a relatively undeveloped area of 
hypervalent iodine chemistry. 
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CH. 1 INTRODUCTION 
 
1.1 Background and Classification of Hypervalent Iodine 
 Iodine is a very unique element.  When looking at the periodic table, one can note 
that it is found toward the lower middle portion on the right side with other p-block 
elements. It can be described as the heaviest non-radioactive element that is a non-metal, 
and other important characteristics include it being the least electronegative and most 
polarizable of the halogens.1,2  It is because of these unique properties that iodine can 
exist in compounds with oxidation states that can vary from +3 (on the left 1) to +7 (on 
the right 2) as seen in Scheme 1 below.   
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Scheme 11 
The first hypervalent iodine compound was first discovered in 1886 by C. Willgerodt, 
who reacted iodobenzene with chlorine gas to give the desired (dichloroido)benzene 3 in 
Scheme 2.3   
I I ClCl
Cl2
CH2Cl2  
Scheme 2 
During that period of time many new hypervalent iodine compounds, including 
iodosylbenzene, (diacetoxyiodo)benzene, and 2-idoxybenzoic acid (IBX) were 
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discovered characterized and then the area of hypervalent iodine chemistry seemed to 
slow.4  Although hypervalent iodine compounds have been known since the 19th century, 
it wasn’t until recently hypervalent iodine chemistry has seen a large resurgence in 
interest with countless new reagents such as the famous Dess-Martin reagent for the 
oxidation of alcohols, along with countless journal articles and a number of books being 
published.1,4,5,6,7,8,9,10  These compounds are of great importance because hypervalent 
iodine containing compounds can be used for a variety of reactions such as C-C bond 
formations, iodinations, and oxidations, while maintaining a benign environmental 
character and easy commercial availability compared to other reagents containing heavy 
metals such as palladium, chromium or lead.1,2,10   
 The term hypervalent comes from the ability of the iodine in the molecule to exceed 
its normal octet of eight valence electrons, commonly containing ten or twelve electrons 
instead.11  Scheme 31 below depicts a general structure of a hypervalent iodine molecule 
4.  The bonding in a hypervalent iodine-containing molecule is quite unique.  Two 
electrons reside in bonding and non-bonding molecular orbitals, while the antibonding 
orbitals remain empty.  This gives rise to what is known as a three-center, four-electron 
bond (3c-4e) where two electrons are delocalized to the ligands giving rise to a charge 
distribution of approximately +1 on the central iodine atom and -0.5 on each of the 
ligands.1  Because of this special bonding, the iodine to ligand (L) bonds are longer and 
weaker, thus giving important reactive character to the molecule in consideration.  A 
normal covalent bond exists between iodine and the least electronegative element, 
depicted in the Scheme 3 as R, and the molecule takes on a distorted, trigonal 
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4 
bipyramidal geometry with an over all T-shape1. 
I
R
LL
Antibonding MO
Nonbonding MO
Bonding MO
 
Scheme 31 
 Most commonly, iodine (III) and iodine (V) reagents are used in organic chemistry 
today and some examples be seen in Schemes 4 and 5 respectively below. 
I
O OO
O
I
HO O
S
O
O
(Diacetoxyiodo)benzene (DIB) Hydroxy(tosyloxy)iodobenzene(Koser's Reagent)  
Scheme 4 
(Diacetoxyiodo)benzene 5 and Koser’s Reagent 6 are very common λ3-iodanes and have 
found use in such reactions as oxidations of olefins, ring expansions and contractions, 
synthesis of iodonium salts, and oxidations.12  The IUPAC nomenclature uses the λn 
notation to designate a heteroatom in a non-standard valence state n.1 
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Scheme 5 
Two examples of λ5-iodanes, 2-iodoxybenzoic acid (IBX) 7 and its derivative Dess-
Martin Periodinane (DMP) 8, are shown in Scheme 5.  These two reagents are most 
commonly used as efficient oxidants in organic chemistry with the most common 
application being the oxidation of alcohols 9 to their carbonyl derivative 10, Scheme 6.10   
R
OH
R
R
O
R
DMP
R= H, Alk, Ar  
Scheme 610 
DMP was synthesized by heating IBX in an acetic anhydride/acetic acid mixture as 
shown in Scheme 7.10,13  The synthesis of DMP was found to be extremely important 
because of its increased solubility compared to IBX, which is insoluble in most organic 
solvents and water, besides dimethyl sulfoxide (DMSO).10,13 
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Scheme 7 
 Since the focus of this thesis is on λ3-iodanes, only the reactivity of this hypervalent 
iodine species will be discussed.  The reactivity of λ3-iodanes can be seen in a more 
detailed mechanism in Scheme 8 and take into account the special characteristics of the 
iodine-ligand bonds and can be viewed as a ligand exchange process.1  A nucleophile 
attacks the iodine center in 11 causing exchange of one of the ligands.  This step is then 
followed by immediate reductive elimination of iodobenzene 12, or pseudo rotation to a 
more favorable conformation followed by reductive elimination of iodobenzene 12 to 
IPh
L
L
+ Nu
L-
IPh
L
Nu
Ligand Exchange Reductive Elimination
Nu+  +  L-
I
Ph
L
Nu
PhI
Nu L
Ligand Coupling
Pseudo-rotation
PhI
 
Scheme 81 
give the coupled nucleophile-ligand product 13.  This is a very favorable process as 
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15 
14 
iodobenzene 12 is a very good leaving group, approximately a million times greater than 
triflate.1  Schemes 9 and 10 depict the two possible pathways of reaction.  In Scheme 9, 
the dissociative pathway, a dissociated ligand 14 creates a positive iodine species 15, 
which is then attacked by a nucleophile.  In the Scheme 10, the associative pathway, a 
nucleophile attacks the partially positive iodine center, followed by pseudo rotation and 
elimination of a ligand. 
IPh
L
L
L-
IPh
L
Nu- IPh
L
Nu
 
Scheme 91 
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Scheme 101 
The next parts of this chapter will deal specifically with hypervalent iodine and imide 
chemistry as it relates closely to the focus of this research. 
 
1.2 Hypervalent Iodine and Imides 
 As previously stated, λ3-iodane compounds have been known for quite awhile, but 
aryl iodine(III) compounds containing two nitrogen bonds weren’t discovered until 1983 
when the research group of Varvoglis discovered bis(phthalimidate) 16, through a ligand 
exchange reaction of potassium phthalimidate 17 with 
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16 18 
17 
[bis(trifluoroacetoxy)iodo]benzene) (PIFA) 18 in acetonitrile as shown in Scheme 11.14 
I
O
O
F3C
O O
CF3
K+
O
O
N-
2 eq.
MeCN 
RT
12 h
I
O
O
N
O
O
N
74%
+
F3CCOOK
 
Scheme 11 
The compound was noted to be very insoluble in typical organic solvents and was 
characterized through elemental analysis and infrared spectroscopy.  Afterwards, the 
bis(phthalimidate) 16 was shown to have interesting reactive properties.  As described in 
the same article, Scheme 12 demonstrates various reactions that were possible between 
water, acetic acid, molecular iodine and bromine, and also acetophenone with the new 
bis(phthalimidate) 16.14  In water the bis(phthalimidate) reagent 19 is hydrolyzed slowly 
and thus converted to idosylbenzene 20 and phthalimide 21 over time.  When reacted 
with acetic acid, the bis(phthalimidate) 19 undergoes ligand exchange to give 
(diacetoxyido)benzene 22 and phthalimide 23 by the usual ligand exchange mechanism 
previously discussed for λ3-iodane compounds. 
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Scheme 1214 
When reacted with elemental iodine or bromine, the reagent affords iodobenzene 24 and 
either N-bromo- or N-iodophthalimide 25.  Interestingly, when bis(phthalimidate) was 
reacted with acetophenone at high temperatures in carbon tetrachloride, N-
phenacylphthalimide 26 was found to be produced in low yields. 
 In the same year, the research group of Varvoglis later expanded on the project and 
created a variety of phenyl iodine(III) bisimidates using the sodium salts of several more 
imides shown in Scheme 1315. Some imides used in the general synthesis of Scheme 13 
included saccharin 27 and succinimide 28.  As before, the resulting compounds were 
typically insoluble in ordinary organic solvents and were characterized by infrared 
spectroscopy, melting point, and elemental analysis.  Similar reactions as found in 
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30 
Scheme 12 were applied once again with similar results. 
Scheme 13 
A year later, the same group reported on the reaction of (disaccharinyliodo)benzene 29 
with various ketones as shown in Scheme 14 to afford the corresponding α-saccharin 
derivatives 30.16 
I
O
N
S
OO
O
N
S
O O
R1
O
R2
5-10 mL
65oC-Reflux
R1
O
R2O
N
S
OO
 
Scheme 14 
The reaction was carried out using 1 equivalent of the (disaccharinyliodo)benzene 29 5-
10 mL of the ketone, which was used neat as a solvent.  A total of seven examples were 
shown with yields ranging from 18-75%, however acetophenones containing electron-
withdrawing groups were found to be unreactive.  The authors hypothesized that this 
O
O
Na
N
O
NNa
S
OO
Na
N OO
Na
N
NH
OO
N
Na
N
N
Na
N O
N
Na
O
O
NaN
H
NO O
O
Et
Et
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36 
reaction takes place via a free-radical mechanism. 
 
1.3 Hofmann Rearrangement of Phthalimide 
 Another interesting reaction utilizing imides and hypervalent iodine is known as the 
Hofmann Rearrangement.  The Hofmann Rearrangement is a useful reaction that 
traditionally allows for the conversion of an amide (benzyl amide 31) in a basic solution 
containing elemental bromine into a carbamate 32 and followed decarboxylation to give 
the respective amine 33 as shown in Scheme 15.17 
PhH2C NH2
O
NaOH, Br2
H2O
PhH2C N C O PhH2C NH2
 
Scheme 1517 
In 2010, Zhdankin et al. reported that alkyl carboxamides 34 could be converted to their 
corresponding amines 35 through the Hofmann Rearrangement by using an in situ 
generated hypervalent iodine species PhI(OH)+ 36 from Oxone and iodobenzene in an 
aqueous acetonitrile solution as shown in Scheme 16 with excellent yields (75-97%).17  
R NH2
O
PhI (1 eq.)  Oxone (2 eq.)
CH3CN-H2O, rt
R
HN O
O
Ph I
OH
HSO4
 
Scheme 16 
In 2012 Togo et al. described the Hofmann-type reaction of phthalimides 36, as well as 
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36 37 
39 
38 
40 
41 
other various aliphatic imides, as shown in Scheme 17 to afford the corresponding 
anthracilic and amino acid derivatives 37 in good yields.18  
O
O
NH
PHI (1.3 eq.)
m-CPBA (1.4 eq.)
TsOH-H2O (1.4 eq.)
K2CO3 (4 eq.)
Na2SO4 (2 eq.)
MeOH, rt
CO2CH3
NHX
X= CO2CH3 or H
93%
R R
 
Scheme 1718 
The reaction is proposed to proceed through an in situ generated iodine(III) reagent 38 
that is created through the reaction of iodobenzene 39, m-CPBA, and p-toluenesulfonic 
acid.18  The generated Koser’s reagent 38 reacts in a basic solution with the imide to 
afford an imide-combined hypervalent structure 40.  Reaction with methanol allows for 
ring opening, followed by rearrangement and leaving of iodobenzene.  The desired  
I
m-CPBA
TsOH-H20 PhI(OH)(OTs)
Base
Na2SO4
MeOH
O
O
N I
L
Ph
CH3O
CO2CH3
O
N
I
Ph
L
-PhI
N
CO2CH3
C O
CH3O
CO2CH3
NHCO2CH3  
Scheme 18 
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42 
45 44 
43 
carbamate 41 is achieved by further reaction with an alcohol.  The final products from 
Hofmann-type rearrangements have important use in the pharmaceutical industry.17,18,19 
 
1.4 Metal-Free Diamination of Styrenes 
 Carbon-nitrogen bond formation was further explored by the Muniz research group 
through the reaction of an iodine(III) reagent containing a bissulfonimide moiety with 
various alkenes.20,21  This paralleled previous diamination reactions that utilized 
palladium, thallium, mercury, or copper in catalytic amounts.21 
I OAc2
CH2Cl2
RT, 1h
-HOAc
I
NR2
OAc
HNR2
R=Ts or Ms
 
Scheme 19 
The reaction of (diacetoxyiodo)benzene 42  with a bissulfonimide in Scheme 19 results 
in the formation of a monosubstituted-bissulfonimide hypervalent iodine compound 43 
via ligand exchange. 
R CH2Cl2, 0oC
H NR2
NR2
R
HNR2 (2.4 eq.)
I
NR2
OAc
1.2 eq.
 
Scheme 20 
The formed reagent 43 is then used to react with various styrenes and alkenes 44 which 
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46 
47 
attack the iodine center, generate an iodo(III)amine which forms an aziridium 
intermediate which undergoes nucleophilic opening by a bissulfonimide ion to generate 
the corresponding diamine 45.20 
R
NMSs
NMSs
1. Red-Al (excess)
THF (86%)
R
NH3Cl
NH3Cl
2. BzCl, NaH, THF, RT
3. Bu2SnH, AIBN,
toluene, 110oC
4. 6 m HCl, dioxane
NaOH
R
NH2
NH2
 
Scheme 21 
Scheme 21 above shows the utility of a diamination reaction utilizing bissulfonimide 
groups as they can be deprotected and converted into the corresponding diamines 47, 
which are useful as precursors to pharmaceutical agents such as (S)-levamisole.20 
 
1.5 C-H Insertion of Arenes Using Imides 
 Another important reaction of hypervalent iodine reagents and imides is the C-H 
insertion reaction.  This reaction is important as it gives a way for C-N bond formation on 
an aromatic ring, which is typically performed using heavy metal catalysts, which are 
shown in the following schemes. 
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51 
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52 53 54 
H
R
+
O
O
NH
0.1% Pd Cat
PhI(OAc)2
NR2
R
O
NH
S
OO
or
MeCN, 100oC
24 h
 
Scheme 22 
In 2013, Hartwig, et al. demonstrated that various arenes 48 could be reacted with 
phthalimide 49 or saccharin 50 with a palladium catalyst and (diacetoxyiodo)benzene to 
afford the desired aminated arene 51 in good yields.22 
DG
H
O
O
N+ OTs
[RhCp*Cl2]2 (5 mol %) DG
NPhth
AgSbF6 (40 mol %)
DCE, 100 oC
 
Scheme 23 
Research by Li et al. has shown an efficient amination of various arenes 52 with N-
arenesulfonated imides 53 using rhodium and gold catalysts to yield twenty-three 
examples of phthalimide aminated arenes 54 in good yields (48-87%).23 
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60 59 58 
56 55 57 
DG
H
+
O
O
NH CuOAc (20 mol%)
O2
DG
NPhth150
oC
 
Scheme 24 
Another parallel reaction using an arene 55 and phthalimide 56 is shown in Scheme 24 
above and uses a copper catalyst to achieve desired products of arene amination 57 at a 
lower cost than the previously mentioned methods.24 
H
R
+
O
O
NH
PhI(OAc2)  (2.5-5eq.)
140-145oC
NPhth
R
MeCN
3 h  
Scheme 25 
DeBoef et al. performed a metal-free version of the amination of substituted arenes 
reactions previously described, in 2011, using a hypervalent iodine reagent  
((diacetoxyiodo)benzene) as an oxidant.25  This method, which is outlined in Scheme 25,  
provides good yields up to 90% without using excess arenes or metal catalysts to achieve 
C-N bond formation.  As shown, various substituted arenes 58 were used along with 
phthalimide 59 to achieve the substituted arene 60.  The reaction was also shown to work 
with succinimide and other substituted phthalimides, but in lower yields.  Each of these 
papers mentions the importance of (hetero)arylamines, as they are valuable targets due to 
their use as agrochemicals, pharmaceuticals, and other natural and biologically active 
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62 
63 
61 
65 63 
64 
products.22,23,24,25  
 
1.6 Imidation of Ketones with Imides 
 Other than the previous work done by Varvoglis on the α-saccharin imidation of 
ketones previously described,16 there currently exists three different pathways for the 
imidation of ketones and these are outlined in Schemes 26-28. 
 
R1
R2
O
X
HNR3R4
R1
NR3R4
O
R2  
Scheme 26 
Scheme 26 describes the first general route for the generation of α-amino ketones.  This 
method utilizes a previously prepared α-halogenated ketone 61 followed by reaction with 
a nucleophilic nitrogen source 63 to afford the α-amino ketone 62 via nucleophilic 
substitution.26 
R1
R2
O
Z-NR3R4
R1
NR3R4
O
R2
or
Z=NR3
Z=halogen, O, or N
 
Scheme 27 
Another variation is shown in Scheme 27 above.  This is a well-described general 
reaction that utilizes a previously prepared, halogenated nitrogen source 64 as an 
electrophile, which is reacted with a ketone 63 to afford the desired α-amino ketone 65, 
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67 66 68 
via electrophilic substitution.26,27 
R1
R2
O nBu4NI/TBHP R1
O
R2130
oC, EtOAc, 3h
O
NH
S
OO
+
O
N
S
O O
 
Scheme 28 
Lastly, Zhang et al. have recently reported on the nBu4NI-catalyzed oxidative imidation 
of ketones 66 with various imides such as saccharin 67 to afford α-imido ketones 68.26  
The reaction likely proceeds via a radical mechanism and worked well with various 
imides such as phthalimide, saccharin, and succinimide while reacting with various 
ketones such as acetone.  This work parallels other nBu4NI-catalyzed coupling reactions 
such as the coupling of aldehydes and aromatic tertiary amines and the synthesis of α-
ketoamides from aryl methyl ketones with dialkylformamides.28,29 
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69 
71 
70 
CHAPTER 2 
RESULTS AND DISCUSSION 
2.1 Synthesis of Hypervalent Iodine Compounds Containing Imides 
A. Introduction 
 Following previously mentioned work by Varvoglis and Muniz groups,14,20 we set 
out to explore hypervalent iodine compounds using imides, with hopes of obtaining a 
metal-free imidation reaction of alkenes.  This would then allow for a much easier 
deprotection of the imide groups into the corresponding diamines.  General imide 
deprotection would follow the process known as Gabriel synthesis.  Scheme 29 below 
depicts the simple process of this reaction.   
O
O
NK
R X
O
O
N R
NaOH CO2-
CO2-
+ R NH2
 
Scheme 29 
Potassium phthalimidate 69 and an alkyl halide are reacted to give alkyl phthalimide 70, 
which is then hydrolyzed under basic conditions to release the primary amine.  Another 
variation of this reaction, shown in Scheme 30, includes the formation of the alkyl 
phthalimide 72 via nucleophilic substitution with an alkyl chloride and phthalimide, 
followed by deprotection with hydrazine and hydrochloric acid to give the primary amine 
73, and is common enough to be performed as an undergraduate experiment.30 
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73 
72 
75 76 
2 eq. 
74 
O
O
N R
H2NNH2
HCl, KOH
R NH2 NH
NH
O
O
+
 
Scheme 30 
It was first chosen to try to work with an imide that had not been previously described in 
the literature as having been incorporated into a hypervalent iodine compound.  
Maleimide was chosen as the starting imide as it has a unique double bond, which could 
potentially allow for further reactions such as Diels-Alder or Michael additions and 
broaden the scope of any subsequent reaction.  
 
B. Results and Discussion 
 Initially, the goal was to provide an easier ligand exchange reaction with an imide 
functional group, HNR2, and a hypervalent iodine reagent to produce a new hypervalent 
iodine reagent with an incorporated imide group.  Rather than working with potassium or 
sodium salt versions of the imides as previously described by Varvoglis, it was 
hypothesized that by reacting an imide with (diacetoxyiodo)benzene 74, it would undergo 
a ligand exchange reaction as shown in Scheme 31 under mild conditions to afford either  
I OAcAcO
RT,
OO
HN
maleimide
I
O
O
N
O
O
NI
O
O
NAcO
Or
-HOAc  
Scheme 31 
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77 
79 78 
PhCl 
2 eq. 
a singly 75 or doubly 76 substituted iodine(III) compound, leaving acetic acid as a 
byproduct, which could easily be removed under deep vacuum.  Unfortunately, after 
trying many variations including changing solvents, times, and temperature, the reaction 
failed to progress successfully.  In fact, when the reaction was heated to help facilitate 
ligand exchange, maleimide appeared to form a polymeric structure 77 as hypothesized in 
Scheme 32.   
I OAcAcO
Heating
OO
HN
maleimide
O ON
R  
Scheme 32 
A polymeric structure is plausible as the reaction yielded a yellow solid, which was 
insoluble in organic solvents and had a melting point greater than 300 0C.  Literature 
sources also explained that maleimide and its derivatives 78 can form polymers 79 from 
the internal double bond, and an example as shown in below in Scheme 33.31 
O ON
R
O ON
R
AIBN, THF
65oC, 18 h
 
Scheme 33 
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80 
83 85 84 
 
PhCl 
1 or 2 eq. 
82 
81 
O
NH
S
OO
saccharin
OO
HN
succinimide
O
O
NH
phthalimide  
Scheme 34 
After these results, it was decided to move on to trying other imides.  The imides listed in 
Scheme 26, succinimide 80, phthalimide 81, and saccharin 82, were each tried under the 
same conditions as in Scheme 31 and Scheme 32 with various results.  Scheme 35 
demonstrates the results of the reaction with succinimide.  Under room temperature and 
varied solvent conditions, both of the desired mono-substituted 84 and di-substituted 85 
products were obtained in mixture in low yields.  Upon heating and rotary evaporation at  
IAcOI OAcAcO
Heating,
>50oC
OO
HN
O
O
N I
O
O
N
O
O
N
+
 
Scheme 35 
temperatures greater than 50 oC, in chlorobenzene, using 1 or 2 equivalents of 
succinimide, the major product of the reaction was the mono-substituted product 84, but 
the resulting solid also contained di-substituted product 85 as well as unreacted 
(diacetoxyiodo)benzene 83, which were impossible to remove under varying 
recrystallization and washing methods as the solubility of the molecules appeared to be 
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88 86 
87 2 eq. 
89 
similar.  Subsequent reactions with phthalimide 81 resulted in a mainly di-substituted 
product, but we were unable to purify well enough to get a reliable elemental analysis. 
I OAcAcO
CH2Cl2
RT, 6h
I
O
S
O
N
O
S
O
N
O
NH
S
OO
O
O
 
Scheme 36 
Upon reacting DIB 86 with two equivalents of saccharin 87 in dichloromethane, as 
shown in Scheme 36, after 6 hours the desired highly insoluble di-substituted product 88  
Scheme 37 
was achieved in yields greater than 90% and the result was confirmed via elemental, 
NMR, and IR analyses.  A detailed mechanism of the ligand exchange is given in 
I OAcAcO
O
HN
S
O O
IAcO
O
N
S
O O
H
AcO-
IAcO
O
N
S
O
O
I
O
N
S
O OO
N
S
OO
+ AcOHRepeat
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Scheme 37.  To help prove that the mechanism goes through a mono-substituted product 
89, the reaction time was shortened to a half-hour and the 1H NMR analysis is shown 
below in Scheme 38.  After reacting for a half hour, it is possible to see three different 
compounds present in 1H NMR analysis, unreacted DIB, and the mono and di-substituted 
products.  Unfortunately, only the di-saccharin product could be purely obtained as 
varying the time and amount of starting reagents always led to a mixture, unless enough 
time had elapsed to fully convert the starting materials to the insoluble di-product, which 
could be purified via washing with organic solvents and filtering.  
 
Scheme 38 
Lastly, a mu-oxo variation of the di-saccharin product 88 was synthesized by 
Scheme 39. 
I O
O
O
O HH
IO
N
S O
O O
N S
O O
H H
I
O
O
O
N
S O
O
HH
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90 
96% 
I I
O
O
N S
O O
O
NS
OO
I OAcAcO
1.1 eq saccharin
2 mL CH2Cl2
2 mL H2O
RT 24 h1 eq.
 
Scheme 39 
The new mu-oxo di-saccharin product 90 was afforded in good yields through the 
reaction of DIB and saccharin in water and dichloromethane solution.  This reaction 
paralleled a similar reaction with bistosylimide.21  These oxygen-bridged molecules have 
been noted by Kita et al. to be very reactive.32 
 
C. Summary 
When trying to find a hypervalent iodine reagent containing an imide functional 
group under mild reaction conditions, maleimide polymerized upon heating and 
succinimide provided a mono-substituted product, but could not be isolated due to 
impurities that could not be removed due to their similar solubility.  Column 
chromatography was not a feasible answer as hypervalent iodine compounds readily 
degrade on acidic silica gel.  Phthalimide was found to predominately form a di-
substituted iodine(III) compound, but could not be purified as well.  Saccharin readily 
formed a di-substituted iodine(III) product under mild conditions in good yields when 
reacted with DIB, and when water was added at the start of the reaction, a novel oxygen-
bridged molecule was formed.  The observed reactivity of the imides with DIB was most 
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likely due to their pKa values, saccharin 1.8, maleimide 9.5, phthalimide 8.3, and 
succinimide 9.6.  The extra electron-withdrawing group on saccharin helps make the N-H 
bond more acidic and allows for ease of ligand exchange.  
 
2.2 Imidation of Silyl Enol Ethers 
A. Introduction 
 Now that two good starting materials were characterized, both of which contained 
saccharin as the imide, the next step was to determine if they were valuable as reagents.  
As stated previously, the goal was to create a metal-free imidation of alkenes reaction 
with an imide-containing iodine(III) reagent similar to the ones described by the Muniz 
research group.20,21  A series of attempted reactions and the results are discussed in the 
following section. 
 
B.  Results and Discussion 
Using the previously mentioned reagents, many attempts were made to react them 
with various alkenes including styrenes, aliphatic alkenes, and cyclic alkenes with no 
apparent success.  This included varying solvents, temperatures, and even using Lewis 
acid catalysts.  Other attempts were made with alkynes and C-H insertions, with negative 
results as well.  Upon heating the mu-oxo reagent 90 at reflux in benzene to attempt a C-
H insertion reaction, the compound was deoxygenated back into the di-saccharin 88 
molecule.  Finally, after many negative results, a reaction with 1-phenyl-1-
trimethylsiloxyethylene 91 was noted with the mu-oxo reagent 90 as shown in the 
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91 92 
generalized Scheme 40 to give the α-imido ketone 92 and the conditions of this first 
reaction are described in entry 1 of Table 1.  At this time, it was believed that a strong 
acid was necessary to break the apart the starting saccharin containing reagent in order to 
catalyze the reaction. 
OSiMe3
Conditions
Table 1
O
O
N
SO
O
 
Scheme 40 
 
Table 1 
Entry Starting 
Material 
(eq.) 
Excess 
Saccharin 
(eq.) 
Solvent 
1.5mL 
Acid 
(1 eq.) 
Temp 
oC 
Time Yield 
[%]a,b 
1* mu-oxo  
(1) 
1 CH2Cl2 TFOH RT 12 h 5b 
2 mu-oxo 
(1) 
1 CH2Cl2 TFOH RT 24 h 15 
3 mu-oxo 
(1) 
1 CH2Cl2 TFOH 00Cà
RT 
24 h 3 
4 mu-oxo 
(2) 
0 CH2Cl2 TFOH RT 24 h 13 
5* mu-oxo 
(1) 
0 MeCN TFOH RT 24 h 56 
6 mu-oxo 
(1) 
0 Et2O TFOH RT 24 h Trace 
7 mu-oxo 
(1) 
0 CHCl3 TFOH RT 24 h Trace 
8 mu-oxo 
(1) 
0 acetone TFOH RT 24 h 23 
9 mu-oxo 
(1) 
0 MeOH TFOH RT 24 h 17 
10 mu-oxo 
(1) 
0 EtOAc TFOH RT 24 h 0 
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11* None 1 MeCN None RT 24 h 0 
12* None 1 MeCN TFOH RT 24 h 0 
13* di-saccharin 
(0.6) 
0 MeCN None RT 24 h 54 
14* mu-oxo 
(1) 
0 MeCN None RT 12 h 69 
15* mu-oxo 
(0.6) 
0 MeCN None RT 2 h 66 
16* mu-oxo 
(0.6) 
0 MeCN None RT 2h 70 
(68b) 
17* acetophenone 
(No silyl enol 
ether) 
1 MeCN None RT 2 h 0 
18* acetophenone 
mu-Oxo 
(1) 
(No silyl enol 
ether) 
 
0 MeCN None RT 2 h 0 
aYields are calculated with 1H NMR using tetrachloroethane as a standard. bIsolated 
yields after purification.  
 
1-Phenyl-1-trimethylsiloxyethylene 91 was chosen as a starting silyl enol ether for 
optimization because of its simple structure and commercial availability.  Upon further 
optimization, it was found that acetonitrile gave the best yield as a solvent, entry 5, and 
that a strong acid was in fact not needed for the reaction to occur, entry 14.  Optimized 
time was two hours and entries 11, 12, 17, and 18 were included as blank reactions to 
show that the starting hypervalent reagent and silyl enol ether were both necessary for the 
reaction to occur.  Di-saccharin reagent 88 gave an approximately 15% lower yield when 
compared to the mu-oxo type, entries 13 and 16, which corresponds to the high reactivity 
of these reagents described by Kita et al.32  It is most likely due to increased 
nucleophilicity at the iodine center when compared to the di-saccharin compound with 
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93 94 
two stabilizing imide groups at the iodine center.  It was also important to note that only 
0.6 equivalent of the reagent was required for the reaction to occur, which was helpful 
with describing the mechanism.  Scheme 41 describes the optimized reaction condition 
between a generic silyl enol ether substrate 93 and our starting reagent, which allowed for 
the conversion to the corresponding α-imido ketone 94.   
R2
R1Me3SiO
R3
Mu-Oxo Reagent 0.6 eq.
1.5 mL MeCN
2 h R2R1
O
R3
O
N
SO
O
 
Scheme 41 
Table 2 below describes the results of the optimized reaction with varying substrates. 
Table 2 
Substrate Product   Yield [%]a 
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OSiMe3
OSiMe3
Br
O O
N
S
O
O
O O
N
S
O
O
F
O
O
N S
O
O
OSiMe3
F
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O
O
N
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O O
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Br
OSiMe3
H3CO
OCH3
O
H3CO
H3CO
O
N
S
O O
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95 
 
 
 
 
78b 
 
  
 
42b 
  
 
 
19b 
a Isolated yields after purification. b Yields determined by 1H NMR using a 
tetrachloroethane standard. 
An attempt to increase the yields of a reaction with a substrate 95 that had given 
low yields for this reaction is shown in Scheme 42 and Table 3.  The tested 
reactions still utilized the same mu-oxo reagent, but the amount used, temperature, 
and time conditions were varied.  The change in yields was determined to 
negligible. 
OSiMe3
Conditions
Table 2
O
O
N
SO
O
 
Scheme 42 
NC
OSiMe3
OSiMe3
OSiMe3
H3CO
O O
N
S
O O
NC
O O
N
S
O O
H3CO
O O
N
S
O O
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Table 3 
Entry Starting Material 
(eq.) 
Temp 
oC 
Time Yield  
[%]a,b 
1 0.6  RT 15 h 34 
2 1.2  RT 5 h 37 
3 0.6 Hot Plate 
100 oC 
2 h 32 
4 0.6 0o C to 
RT 
5 h 30 
5 0.6 RT 2 h 36  (33b) 
aYields are 1H NMR yields calculated using tetrachloroethane as a 
standard. bIsolated yields after purification. 
 
Because the yields were not 100%, it was unsure what exactly was happening to the 
remaining starting substrate if it was not being completely converted into its α-
imido ketone, but still being transformed into something other than the methyl 
ketone from which it was derived.  Upon careful chromatography, we elucidated 
what appears to be a rearrangement of the saccharin moiety, which is bound to the 
substrate via a carbon-oxygen bond, rather than by a carbon-nitrogen bond.  Two 
examples of this are shown in Table 4 and these products appear to be where the 
rest of the reaction proceeds, if not bound to the substrate via a carbon-nitrogen 
bond.  Also, only a few examples of these products were obtained, as these 
compounds appeared to decompose or bind to alumina gel during chromatography 
and were often difficult to purify when compared to their nitrogen bound counter 
part.  The mechanism that is proposed for this reaction to yield these results is 
shown in Scheme 43. 
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Table 4  
 
Substrate 
 
Product 
 
Yield [%]a 
 
 
 
 
 
29 
 
 
 
 
67 
a Isolated yields after purification. 
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Scheme 43 
As with most reactions with λ3-iodane species, the mechanism uses a ligand exchange 
explanation at the iodine center.  The double bond from the silyl enol ether acts as the 
nucleophile, which attacks the iodine center.  Ligand exchange causes the formation of a 
saccharin nucleophile, which can attack the electrophilic carbon via a nitrogen 
nucleophile 96 or rearrange and react as an oxygen-based nucleophile 97 followed by 
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100 
101 
reduction of the hypervalent iodine to afford either the α-imido ketone 99 or the oxygen-
bridging α-imido ketone 98.  Both α-nitrogen 100 and α-oxygen bound 101 ketone 
products have been reported in a previous literature article describing the synthesis of a 
similar molecule as shown in Scheme 44.33  The reaction is predicted to proceed in a 
similar fashion at the iodine on the other side of the mu-oxo reagent, as only 0.6 
equivalents are needed for the optimized reaction. 
O
NNa
S
O
Br
O
O
N S
O
O
N
S
+
Benzene, Reflux 
3h
 
Scheme 44 
As for importance of this reaction, the desired products from our reported method 
have recently found use as precursors to many new possible pharmaceutical 
agents.34,35,36,37,38  As an example, Shahwar et al. utilized compound 102 to prepare 
benzothiazine derivatives such as 103 in Scheme 45, which are noted to be active 
acetylcholinesterase inhibitors and have found application in the treatment of Alzheimer 
and Parkinson’s disease.34   
  36 
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O O
O OH
HN
S
O O
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O O
H3C
C2H5OH/Na
DMS
 
Scheme 45 
Schninazi et al. has also reported on the synthesis of benzothiazine derivatives 104 shown 
in Scheme 46 below utilizing the same precursor 102 for use as potent anti-HIV-1 
agents.35 
SO2
OHN
N
R
N NH
 
Scheme 46 
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105 106 
Alkylated saccharin derivatives, 105 and 106, which are similar to the ones synthesized 
by our new method, were also used in studied by Supuran et al. as selective inhibitors of 
tumor-associated carbonic anhydrase36.  These were synthesized by saccharin alkylation 
using alkyl bromides. 
R
O
O
N S
O O
R
O
N S
O O  
Scheme 47 
 
C. Summary 
Herein we present a new imidation reaction of silyl enol ethers to afford α-
saccharin ketones in moderate yields, under mild conditions without the use of metal 
catalysts.  These imido ketones were synthesized from aliphatic, aromatic, and 
heterocyclic starting substrates, with aromatic substrates giving the best yields.  The 
reaction mechanism is hypothesized using a traditional ligand-exchange explanation at 
the hypervalent iodine center of the starting reagent.  Both nitrogen-bound and oxygen-
bound products were noted in the reactions.  It has been hypothesized that this mixture 
occurs due to a rearrangement of the nucleophile to a more favorable conformation that 
allows the saccharin molecule to get closer to the substrate to react, as this has been 
shown to be the more favorable product in sterically hindered substrates.  Higher yields 
of α-imido ketones from the aromatic precursors most likely occurs from their higher 
reactivity, which stems from electron donation into the double bond from the aromatic 
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ring.  The synthesized products are important precursors to biologically active 
compounds. 
 
2.4 Preparation of a New, Soluble Mu-Oxo Hypervalent Reagent 
A. Background 
Even though the reaction in Scheme 41 proceeded effectively, it was important to 
determine the exact structure of the reagent to show that these theorized hypervalent 
iodine-imide bonds do exist.  As previously discussed and also explained by the 
Varvoglis research group, bis(imidates) were found to be very insoluble in ordinary 
organic solvents and crystallization was not possible.14  This prompted us to attempt to 
synthesize a similar molecule, which would be soluble in ordinary organic solvents to 
allow crystallization and thus analysis by x-ray crystallography.  One attempt at a soluble 
reagent was based on results obtained from Zhdankin’s research group, while the other 
attempt was based on results from Kita’s research group, who recently discovery 
hypervalent iodine compounds of the mu-oxo variety containing two acetate groups as 
well as a bridging oxygen atom in 2012.39,32  These mu-oxo type reagents were found to 
be much more reactive than their normal iodine(III) counterparts.  It was hypothesized 
that these reagents could undergo a similar ligand exchange reaction as we had found 
with (diacetoxyiodo)benzene and saccharin, while being able to obtain a more soluble 
compound.   
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107 108 
109 110 111 
B. Results and Discussion 
 Recently, Zhdankin et al. reported on the preparation of a highly soluble carbene 
precursor.39  Using the steps in their proposed schemes, we first synthesized iodobenzene 
with ortho-alkoxy groups 108 from 2-iodophenol 107 as shown in Scheme 48. 
I
OH
RBr I
ORK2CO3
DMF, 50 oC
R= Me, Pr, iPr, Bu
88-95%  
Scheme 48 
The o-alkoxy iodobenzene 109 was oxidized leading to the diacetate iodine(III) reagent 
110, which was then reacted with two equivalents of saccharin to undergo ligand 
exchange and afford the new di-saccharin reagents 111 in good yields.    
I
OR
I
OR
OAcAcO I
OR
NR2R2N
O
NH
S
OO
2.1 eq.
CH2Cl2
RT, 6 h
AcOOH
AcOH
57-84%
R= Me, Pr, iPr, Bu >80%  
Scheme 49 
Unfortunately, the introduction of an o-alkoxy group did not appear to greatly 
increase solubility.  The second attempt at making a soluble reagent is shown in Schemes 
50-52. 
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 112 113 
114 
115 
I
PIFA
BF3 Et2O
CH2Cl2
-78oC
5h
I
I
 
Scheme 50 
Scheme 50 and 51 are followed from the literature.38  The first step, was a coupling 
reaction of 1-iodo-3,5-dimethybenzene 112 shown in Scheme 50 using PIFA and a Lewis 
acid catalyst.  The resulting product 113 could be oxidized as shown in Scheme 51 to 
afford the µ-oxo bridged hypervalent iodine(III) molecule 114, which is reacted with 2 
equivalents of saccharin to afford 115 in Scheme 52 in a 63% yield. 
I
I Selectfluor (4)
AcOH
MeCN
RT 24h
I I
O OO
O
O
 
Scheme 51 
O
NH
S
OO
2 eq
CH2Cl2
RT
>24h
I I
O OO
O
O
I IO
O
N S
O OO
N
S O
O
 
Scheme 52 
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The resulting structure 115 was isolated in 63% yield and found to be easily soluble in 
ordinary organic solvents such as acetonitrile and chloroform.  Immediately, the 
compound was characterized and then began the attempt at obtaining a crystal suitable 
for x-ray analysis.  Recrystallization in acetonitrile yielded single crystals suitable for x-
ray crystallographic analysis.  Scheme 53 shows the structure of the resulting crystal with 
important bond lengths shown and Scheme 54 shows the packing arrangement of the 
molecules. 
 
Scheme 53 
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0
a
c
b
 
Scheme 54  
To our knowledge, this is the first x-ray to show a hypervalent iodine to imide bond.  
Other published structures containing hypervalent iodine-nitrogen bonds are shown in 
Scheme 55 with their important bond lengths noted.40,41,42,43,44,45 
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Scheme 55 
 
 
2.5 Summary 
Di-saccharin iodine(III) molecules containing an o-alkoxy group did not appear to 
show significant solubility in organic solvents.  Adapting a synthetic method from Kita et 
al., we were able to synthesize a di-saccharin reagent soluble in ordinary organic 
solvents.32  The valuable crystal structure in Scheme 53 helps to support our hypothesis 
of our precursor µ-oxo reagent also containing two iodine-nitrogen bonds and is the first 
of its type to be proven via x-ray analysis.  The structure is also compared to compounds 
containing similar bonding as shown in Scheme 55. 
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2.6 Future Directions 
 As a continuation of this project, it will be important to finish fully characterizing 
and obtaining isolated yields from the reaction of the substrates on the bottom of Table 2 
to show its broad applicability.  In addition, single crystals of compound 3s have been 
grown in acetonitrile and await x-ray analysis.  These crystals will be important, as they 
will be able to prove that the rearrangement of the saccharin nucleophile shown in 
Scheme 43 does exist, and that some of the reaction progresses toward an oxygen-bound 
product as shown in 97, as well as the desired C-N bond formation. 
As another future direction, it would be interesting to explore the deprotection of 
the saccharin moiety, giving rise to either primary or secondary amines, which are 
extremely useful as pharmaceutical agents.46  The deprotection of saccharin is a fairly 
unexplored area, with only a few papers fully describing its reaction process.  As seen in 
Scheme 56 below, Abe and Sugasawa have developed a simple method for the 
preparation of primary and secondary amines from alkylated saccharin.47  The alkylated 
saccharin 116 was first alkaline-hydrolyzed using aqueous sodium hydroxide, alkalized a 
second time to eventually afford a secondary amine or left as is and then treated under 
basic and acidic conditions yielding either the primary or secondary amines 117. 
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Scheme 56 
 
 
 
 
 
 
 
 
 
 
 
 
  46 
 
CHAPTER 3 
EXPERIMENTAL 
 
3.1 General Methods 
NMR Spectra were recorded using a Varian UNITY INOVA 500 MHz NMR 
spectrometer operating at 500 MHz (1H NMR) and 125 MHz  (13C NMR) with 1H and 
13C chemical shifts referenced to the corresponding solvent and recorded in parts per 
million (ppm).  Each of the melting points was determined with an open capillary tube 
with a Mel-temp II® melting point apparatus and the values are uncorrected.  High-
resolution mass Spectra (HRMS) was determined with a Bruker BioTOF II Reflectron 
ESI-TOF instrument at the University of Minnesota Twin-Cities campus. Microanalysis 
was performed by Atlantic Microlab Inc., Norcross, Georgia.  IR Spectra were recorded 
on a Perkin Elmer Spectrum 100 FT-IR Spectrophotometer scanned from 4000 cm-1 to 
450 cm-1 and the peaks were recorded in inverse centimeters (cm-1). Pre-coated silica gel 
60 F254 plates from MERCK were used to determine proper separation and reaction 
completion conditions and the spot markings were distinguished using UV light at 254 
nm. 
 
3.2 Materials 
 All of the commercial reagents and solvents were ACS grade and used without 
any further purification or distillation.  For column chromatography, silica gel was 
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obtained from Dynamic Adsorbents Inc., 63-200µm, 60A and basic alumina oxide, 50-
200µm, 60A, was obtained from Acros Organics. 
 
3.3 Synthesis of Compounds 
1-iodo-2-methoxybenzene (3a)39 
OCH3
I
 
Synthesized according to the literature procedure by Zhdankin et al.39  10.0 mmol of 2-
iodophenol was mixed with 50.0 mmol potassium carbonate in 10 mL DMF and allowed 
to stir for 10 minutes.  15.0 mmol of methyl bromide was added and the reaction was 
stirred at 50 oC for 3 h.  The mixture was purified via column chromatography (3:1 
hexanes/ ethyl acetate) to afford pure 1-iodo-2-methoxybenzene.  The product was 
confirmed via 1H NMR and the spectrum was included for reference. 
 
(2-methoxyphenyl)-λ3-iodanediyl diacetate (3b)39 
OCH3
I
O O
O
O
 
Synthesized according to the literature procedure by Zhdankin et al.39  Peracetic acid was 
formed by the reaction of 30 mL of acetic anhydride and 10 mL of 30% H2O2 at 40oC 
with stirring overnight.  Afterwards, 5.0mmol of 1-iodo-2-methoxybenzene 3a was added 
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to the peracetic acid and the mixture was stirred for 8 h at 40oC.  The mixture was then 
evaporated under reduced pressure and then washed with water and hexanes.  Upon 
drying under vacuum, (2-methoxyphenyl)-λ3-iodanediyl diacetate, was isolated as a 
yellow solid and verified via 1H NMR.  The spectrum is included for reference. 
 
2,2'-(phenyl-λ3-iodanediyl)bis(benzo[d]isothiazol-3(2H)-one 1,1-dioxide) (3c)14 
I
O
N
S
O OO
N
S
OO
 
To a 10 ml round bottom flask, 1 mmol (322 mg) of (diacetoxyiodo)benzene was added 
along with 2 mL of dichloromethane and the mixture was stirred until all of the 
(diacetoxyiodo)benzene was dissolved.  Afterwards, 2.1 mmol (385 mg) of saccharin was 
added and the mixture was allowed to stir overnight.  The solvent was removed under 
reduced pressure and the residue was washed with acetonitrile and diethyl ether, filtered, 
and then dried under vacuum to afford 500 mg (96%) the desired product.  Isolated as a 
white solid; mp 214.5-215.3oC; 1H NMR (CD3OD): δ 8.32-8.31 (d 2H), 7.92-7.80 (2d 
4H, 2t 4H), 7.68-7.65 (t 1H), 7.58-7.55 (t 2H); 13C NMR (CD3OD): δ 163.7, 141.0, 
134.4, 134.2, 133.6, 132.1, 130.8, 128.9, 124.2, 122.8, 120.3; IR (KBr) cm-1 3099, 1698, 
1590, 1456, 1300, 1169; Elemental analysis calcd. for C20H13IN2O6S2: C, 42.27; H, 2.31; 
I, 22.33; N, 4.93; O, 16.89; S, 11.28. Found: C, 42.12; H, 2.31; N, 4.93. 
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2,2'-((2-methoxyphenyl)-λ3-iodanediyl)bis(benzo[d]isothiazol-3(2H)-one 1,1-dioxide) 
(3d) 
I
OCH3
O
N
S
OO O
N
SO
O
 
To a 10 mL round bottom flask, 1 mmol of (2-methoxyphenyl)-λ3-iodanediyl diacetate 
3b was added along with 2 mL dichloromethane.  The mixture was allowed to stir until 
fully dissolved, and then 2.1 mmol (385 mg) of saccharin was added.  The mixture was 
allowed to stir overnight.  The solvent was removed under reduced pressure and the 
residue was washed with acetonitrile and diethyl ether, filtered, and then dried under 
vacuum to afford 527 mg (88%) the desired product.  Isolated as a pale yellow solid; mp 
169.5-170.3 oC; 1H NMR (CD3OD): δ 8.36-8.45 (d 1H), 7.90-7.79 (2d 4H, 2t 4H), 7.71-
7.69 (t 1H), 7.38-7.36 (d 1H), 7.10-7.07 (t 1H), 4.06 (s 3H); 13C NMR (CD3OD): δ 156.7, 
141.4, 137.5, 135.4, 133.9, 133.4, 124.0, 122.3, 120.2, 114.8, 112.1, 105.0, 56.2; IR 
(KBr) cm-1 3091, 3009, 2970, 2940, 2836, 1720, 1640, 1584, 1475, 1338, 1267, 1153. 
 
,2'-(oxybis(phenyl-λ3-iodanediyl))bis(benzo[d]isothiazol-3(2H)-one 1,1-dioxide) (3f) 
I I
O
O
N S
O OO
N
S O
O
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To a 10 ml round bottom flask, 1 mmol (322 mg) of (diacetoxyiodo)benzene was added 
along with 1 mL of dichloromethane and the mixture was stirred until all of the 
(diacetoxyiodo)benzene was dissolved.  Afterwards, 2.0 mL of water was added along 
with 1.1 mmol (202 mg) of saccharin.  1 mL of dichloromethane was added to wash 
down any remaining reagents from the sides of the flask and the reaction was allowed to 
stir for 24 h, making certain the solid residue remains in the liquid portion of the mixture 
and does not build up on the sides of the flask.  The solvent was removed under reduced 
pressure and the residue was gently washed with acetonitrile and diethyl ether, filtered, 
and then dried under vacuum to afford 378 mg (96%) of the desired product.  Isolated as 
a pale yellow solid; mp 175.9-176.6 oC; 1H NMR (CD3OD): δ 8.28-8.26 (d 4H), 7.84-
7.74 (2d 4H, 2t 4H), 7.68-7.65 (t 2H), 7.59-7.55 (t 4H); 13C NMR (CD3OD): δ 166.3, 
141.9, 134.2, 133.6, 133.3, 131.9, 130.8, 129.8, 123.9, 122.8, 120.1; IR (KBr) cm-1 3081, 
3054, 1670, 1485, 1471, 1458, 1305, 1240, 1154, 950; Elemental analysis calcd. for 
C26H18I2N2O7S2: C, 39.61; H, 2.30; I, 32.19; N, 3.55; O, 14.21; S, 8.13. Found: C, 39.79; 
H, 2.33; I, 32.08; N, 3.65; S, 8.17. 
2,2'-diiodo-4,4',6,6'-tetramethyl-1,1'-biphenyl (3g)32 
I
I  
Compound 3g was synthesized using a procedure from Kita et al.32  7 mmol of 3,5-
dimethyliodobenzene in 8.75 mL CH2Cl2 was added drop wise to a stirring solution of 
3.5 mmol PIFA and 7 mmol BF3  Et2O in 8.75 mL CH2Cl2 under argon atmosphere at -
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78 °C.  The reaction was maintained under these conditions for 5 h and then quenched 
with aqueous NaHCO3 and extracted with CH2Cl2.  The desired product 3g was obtained 
by column chromatography using hexanes/ethyl acetate and confirmed via 1H NMR.  The 
spectrum is included for reference. 
 
1,3,9,11-tetramethyl-5λ3,7λ3-dibenzo[d,f][1,3,2]diodaoxepine-5,7-diyl diacetate (3h)32 
I I
O OAcAcO
 
Following the same article by Kita et al., 17.1 mL of AcOH and 1.9 mmol of 3g was 
added successively to a stirring solution of Selectfluor™ (7.6 mmol) in 47.5 mL of 
acetonitrile.  The reaction was stirred overnight at room temperature and the solvent was 
removed under reduced pressure.  The solid was dried and then dissolved in a minimum 
amount of CH2Cl2 and hexane was added drop-wise to precipitate out the desired product.  
This was then dried under vacuum and its identity was confirmed via 1H NMR.  The 
spectrum is included for reference. 
2,2'-(1,3,9,11-tetramethyl-5λ3,7λ3-dibenzo[d,f][1,3,2]diodaoxepine-5,7-
diyl)bis(benzo[d]isothiazol-3(2H)-one 1,1-dioxide) (3i) 
I I
O
O
N S
O
OO
N
S O
O
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To a 10 ml round bottom flask, 0.17 mmol (103 mg) of 3h was added along with 1.5 mL 
of CH2Cl2 and the mixture was stirred until dissolved.  0.34 mmol (62 mg) of saccharin 
was added and the reaction was allowed to stir for 24 h.  The solvent was removed under 
reduced pressure and the residue was gently washed with diethyl ether and dried under 
vacuum to afford 90mg (63%) of the desired product.  Isolated as a pale yellow solid; mp 
130.1-131.2 °C; 1H NMR (CDCl3): δ 8.42 (s 2H), 7.84-7.83 (d 2H), 7.74-7.66 (d 2H, 2t 
4H), 7.54 (s 2H), 2.52, (s 6H), 2.27 (s 6 H); 13C NMR (CDCl3): δ 177.3, 143.7, 141.6, 
139.9, 137.9, 136.4, 135.0, 133.6, 133.3, 129.7, 128.7, 124.6, 120.6, 21.4, 21.3; IR (KBr) 
cm-1 3413, 3070, 3014, 2918, 2863, 1637, 1585, 1458, 1334, 1255, 1154; Elemental 
analysis calcd. for: C30H24I2N2O7S2H2O: C, 41.02; H, 3.21; I, 28.89; N, 3.19; O, 16.39; S, 
7.30; Found: C, 40.72; H, 3.06; I, 28.78; N, 2.98; S, 7.28. 
 Single crystals of 3i suitable for X-ray crystallographic analysis were obtained by 
slow recrystallization from acetonitrile.  X-ray diffraction data was collected on Rigaku 
RAPID II Image Plate system using graphite-monochromated MoKα radiation 
(λ=0.71073 Å). Crystal data for 3i C32H27I2N3O8S2: M 842.46, a = 16.0540(8), b = 
16.6646(7), c = 25.6470 (18) Å, α = 90.00°, β = 90.00°, γ = 90.00°, V = 6861.43 Å3, Z = 
8, R-Factor = 7.73. 
 
General Procedure for Synthesis of Silyl Enol Ethers48,49 
All of the silyl enol ethers were freshly prepared according to a general procedure 
except for 1-phenyl-1-trimethylsiloxyethylene, 1-(trimethylsiloxy)cyclopentene, and 1-
(trimethylsiloxy)cyclohexene, which were commercially available from Sigma Aldrich®.  
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The general procedure was adapted from two articles by Boto et al. where the silyl enol 
ethers were prepared from their corresponding methyl ketones.48,49  TMSOTF (0.804 mL, 
4.2 mmol) was added to 3 mL of dichloromethane and this solution was added drop wise 
to a solution of the triethylamine (1.1mL) and the methyl ketone in (3.5 mmol) in 15 mL 
of dichloromethane which was cooled to 0 °C.  The solution was allowed to stir for 30 
minutes at 0°C and then brought to room temperature (25 °C) and continued to stirring 
for 1 h.  Afterwards, the mixture was diluted with hexanes and washed with a saturated 
aqueous sodium bicarbonate solution and water.  The organic layer was extracted and 
dried over anhydrous sodium sulfate, followed by filtration and rotary evaporation.  The 
resulting oil was then dried under deep vacuum to remove any solvent impurities and 
then used without further purification in the imide transfer reaction.  Confirmation of the 
correct structures was confirmed via 1H NMR and the corresponding spectra are included 
for reference.  
General Procedure for Imide Transfer Reaction 
To a 10 mL pear-shaped round bottom flask, 0.15 mmol (0.6 equivalent) of the 
mu-oxo starting material was added along with 1.5 mL of dry acetonitrile.  A stir bar was 
added and the solution was stirred for 1 minute before the addition of 0.25 mmol (1 
equivalent) of the silyl enol ether, which was added via an Eppendorf pipette.  The 
solution was stirred and monitored via TLC for full conversion of the silyl enol ether.  
When complete, the solution was evaporated under reduced pressure and the NMR yield 
was determined using a 1,1,2,2-Tetrachloroethane standard.  Purification of the desired 
products was achieved using column chromatography with alumina or silica gel and 
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eluting with hexanes/ethyl acetate.  The products were then dried under deep vacuum to 
remove any trace solvent impurities. 
 
2-(3-oxopentan-2-yl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3j)26 
O
O
N
S
O O
 
Reaction of (Z)-trimethyl(pent-2-en-3-yloxy)silane according to the general procedure 
afforded 16 mg (24%) of product after column chromatography using silica gel (1:2.5 
hexanes/ethyl acetate). Isolated as a pale-yellow liquid.  1H NMR (CDCl3): δ 8.071-8.054 
(d 1H), 7.95-7.93 (d 1H), 7.92-7.84 (2t 2H), 4.65-4.61 (q 1H), 2.59-2.55 (m 2H), 1.79-
1.77 (d 3H), 1.10-1.07 (t 3H).  13C NMR (CDCl3): δ 204.5, 158.8, 137.9, 135.0, 134.5, 
126.9, 125.4, 121.0, 56.1, 31.6, 13.8, 7.5; IR (CH2Cl2) cm-1 3039, 2974, 2942, 2875, 
1730, 1460, 1343, 1299, 1260, 1214, 1187. 
 
2-(2-oxo-2-phenylethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3k)26 
O
O
N
S
O O  
Reaction of trimethyl((1-phenylvinyl)oxy)silane according to the general procedure 
afforded 51 mg (68%) of product after column chromatography using silica gel (3:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 193.0-194.0 oC; 1H NMR (CDCl3): δ 
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8.11-8.10 (d 1H), 8.02-8.01 (d 2H), 7.98-7.96 (d 1H), 7.92-7.89 (t 1H), 7.88-7.85 (t 1H), 
7.66-7.63 (t 1H), 7.54-7.51 (t 2H), 5.15 (s 2H); 13C NMR (CDCl3): δ 188.7, 159.1, 138.0, 
134.9, 134.5, 134.2, 134.1, 129.0, 128.2, 127.4, 125.5, 121.2, 44.5; IR (KBr) cm-1 3069, 
2970, 2928, 2857, 1736, 1701, 1595, 1450, 1417, 1335, 1229, 1182; HRMS (ESI): calcd 
for C15H11NNaO4S (M+ Na+): 324.0306; found: 324.0294. 
2-((1,1-dioxidobenzo[d]isothiazol-3-yl)oxy)-1-phenylethan-1-one (3l)33 
O
O
N S
O
O
 
Reaction of trimethyl((1-phenylvinyl)oxy)silane according to the general procedure 
afforded 22 mg (29%) of product after column chromatography using silica gel (3:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 180.3-181.1 oC; 1H NMR (CDCl3): δ 
7.97-7.95 (d 2H), 7.92 (d 1H), 7.91-7.90 (d 1H), 7.82-7.79 (t 1H), 7.77-7.74 (t 1H), 7.68-
7.65 (t 1H), 7.56-7.53 (t 2H), 5.86 (s 2H); 13C NMR (CDCl3): δ 189.4, 169.2, 143.9, 
134.5, 134.4, 133.6, 133.6, 129.1, 127.9, 126.4, 123.8, 122.1, 71.6; IR (KBr) cm-1 3094, 
3069, 2944, 1709, 1616, 1569, 1556, 1471, 1435, 1399, 1325, 1230, 1177, 1057. 
 
2-(2-oxo-2-(p-tolyl)ethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3m)16 
O O
N
S
O
O
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Reaction of trimethyl((1-(p-tolyl)vinyl)oxy)silane according to the general procedure 
afforded 52 mg (66%) of product after column chromatography using alumina gel (1:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 183.1-183.9 oC; 1H NMR (CDCl3): δ 
8.12-8.11 (d 1H), 7.98-7.96 (d 1H), 7.92-7.85 (d 2H, 2t 2H), 7.33-7.31 (d 2H), 5.13 (s 
2H), 2.45 (s 3H); 13C NMR (CDCl3): δ 188.3, 159.2, 145.3, 138.0, 134.9, 134.4, 131.7, 
129.7, 128.3, 127.5, 125.5, 121.2, 44.4, 21.8;  IR(KBr) cm-1 3092, 3040, 2972, 2930, 
1736, 1698, 1606, 1463, 1423, 1335, 1267, 1183. 
 
2-(2-(4-bromophenyl)-2-oxoethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3n)50 
Br
O O
N
S
O
O
 
Reaction of ((1-(4-bromophenyl)vinyl)oxy)trimethylsilane according to the general 
procedure afforded 68 mg (72%) of product after column chromatography using alumina 
gel (1:1 hexanes/ethyl acetate). Isolated as a white solid; mp 191.3-192 oC; 1H NMR 
(CDCl3): δ 8.13-8.11 (d 1H), 7.98-7.97 (d 1H), 7.93-7.87 (2t 2H, d 2H), 7.69-7.62 (d 2H), 
5.10 (s 2H); 13C NMR (CDCl3): δ 188.0, 159.1, 138.0, 135.0, 134.5, 132.8, 132.4, 129.7, 
127.3, 125.5, 121.3, 44.3;  IR (KBr) cm-1 3091, 2983, 2944, 1743, 1693, 1587, 1467, 
1425, 1329, 1225, 1185, 590. 
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2-(2-(4-chlorophenyl)-2-oxoethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3o)26 
Cl
O
O
N S
O
O
 
Reaction of ((1-(4-chlorophenyl)vinyl)oxy)trimethylsilane according to the general 
procedure afforded 55 mg (65%) of product after column chromatography using silica gel 
(4:1 hexanes/ethyl acetate). Isolated as a white solid; mp 184.5-185.1oC; 1H NMR 
(CDCl3): δ 8.12-8.10 (d 1H), 7.98-7.58 (d 1H, d 2H, 2t 2H ), 7.51-7.49 (d 2H), 5.11 (s 
2H). 13C NMR (CDCl3): δ 187.8, 159.1, 140.9, 137.9, 135.0, 134.5, 132.4, 129.6, 129.4, 
127.3, 125.5, 121.2, 44.3.  IR (KBr) cm-1 3094, 2987, 2935, 1746, 1694, 1591, 1458, 
1329, 1227, 749. 
2-(2-(2-chlorophenyl)-2-oxoethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3p)26 
O
O
N S
O
O
Cl
 
Reaction of ((1-(2-chlorophenyl)vinyl)oxy)trimethylsilane according to the general 
procedure afforded 48 mg (57%) of product after column chromatography using silica gel 
(4:1 hexanes/ethyl acetate). Isolated as a white solid; mp 119.0-119.7 oC; 1H NMR 
(CDCl3): δ 8.11-8.10 (d 1H), 7.97-7.96 (d 1H) 7.92-7.85 (2t 2H) 7.74-7.73 (d 1H), 7.49-
7.48 (d 2H), 7.41-7.38 (m 1H), 5.11 (s 2H). 13C NMR (CDCl3): δ 191.5, 159.0, 137.9, 
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135.5, 135.0, 134.5, 133.3, 132.0, 130.9, 130.6, 127.3, 127.2, 125.5, 121.2, 47.1.  IR 
(KBr) cm-1 3097, 3034, 2973, 2929, 1740, 1717, 1697, 1598, 1464, 1434, 1213, 751. 
 
2-(2-(4-fluorophenyl)-2-oxoethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3q)50 
F
O
O
N S
O
O
 
Reaction of ((1-(4-fluorophenyl)vinyl)oxy)trimethylsilane according to the general 
procedure afforded 59 mg (74%) of product after column chromatography using alumina 
gel (1:1 hexanes/ethyl acetate). Isolated as a white solid; mp 176.8-177.5oC; 1H NMR 
(CDCl3): δ 8.13-8.11 (d 1H), 8.07-8.04 (dd 2H), 7.98-7.7.97 (d 1H), 7.93-7.86 (2t 2H), 
7.23-7.19 (dd 2H), 5.12 (s 2H); 13C NMR (CDCl3): δ 187.3, 167.4, 165.3, 159.1, 137.9, 
135.0, 134.5, 131.0, 130.9, 130.6, 130.6, 127.3, 125.5, 121.2, 116.4, 116.2, 44.3.  IR 
(KBr) cm-1 3103, 2988, 2942, 1743, 1694, 1579, 1505, 1467, 1333, 1224. 
 
2-(1-oxo-1-phenylpropan-2-yl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3r)51 
O O
N
S
O O
 
Reaction of (Z)-trimethyl((1-phenylprop-1-en-1-yl)oxy)silane according to the general 
procedure afforded 20 mg (24%) of product after column chromatography using silica gel 
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(3:1 hexanes/ethyl acetate). Isolated as a white solid; mp 154.9-155.5 oC; 1H NMR 
(CDCl3): δ 7.99-7.97 (d 1H, d 2H), 7.92-7.90 (d 1H), 7.88-7.84 (t 1H), 7.82-7.79 (t 1H), 
7.57-7.54 (t 1H), 7.47-7.44 (t 2H), 5.62-5.57 (q 1H), 1.93-1.91 (d 3H); 13C NMR 
(CDCl3): δ 194.2, 158.7, 138.0, 134.9, 134.6, 134.3, 133.4, 128.8, 128.4, 126.8, 125.3, 
120.9, 53.4, 14.6; IR (KBr) cm-1 3095, 3089, 2948, 2904, 1725, 1699, 1597, 1460, 1331, 
1294, 1261, 1191. 
 
2-((1,1-dioxidobenzo[d]isothiazol-3-yl)oxy)-1-phenylpropan-1-one (3s) 
O
O
N S
O
O
 
Reaction of (Z)-trimethyl((1-phenylprop-1-en-1-yl)oxy)silane according to the general 
procedure afforded 57 mg (67%) of product after column chromatography using silica gel 
(3:1 hexanes/ethyl acetate). Isolated as a white solid; mp 171.7-172.6 oC; 1H NMR 
(CDCl3): δ 7.98-7.96 (d 2H), 7.89-7.86 (2d 2H), 7.80-7.72 (2t 2H), 7.66-7.62 (t 1H), 
7.53-7.50 (t 1H), 6.48-6.44 (q 1H), 1.79-1.77 (d 3H); 13C NMR (CDCl3): δ 194.3, 168.5, 
143.7, 134.3, 134.2, 133.8, 133.5, 129.1, 129.0, 128.6, 128.6, 126.5, 123.7, 122.0, 78.0, 
17.7;  IR (KBr) cm-1 3074, 3004, 2944, 1697, 1615, 1598, 1557, 1469, 1406, 1333, 1228, 
1084; HRMS (ESI): calcd for C16H13NO4SNa (M+ Na+): 338.0463, found: 338.0450. 
 
 
  60 
 
2-(2-(benzo[d][1,3]dioxol-5-yl)-2-oxoethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide 
(3t)50 
O
O
O
O
N
S
O O
 
Reaction of ((1-(benzo[d][1,3]dioxol-5-yl)vinyl)oxy)trimethylsilane according to the 
general procedure afforded 45 mg (52%) of product after column chromatography using 
silica gel (3:1 hexanes/ethyl acetate). Isolated as a white solid; mp 202.3-203.3 oC; 1H 
NMR (CDCl3): δ 8.11-8.10 (d 1H), 7.97-7.95 (d 1H), 7.92-7.85 (2t 2H), 7.62-7.59 (d 
1H), 7.46 (s 1H), 6.91-6.90 (d 1H), 6.08 (s 2H), 5.07 (s 2H); 13C NMR (CDCl3): δ 186.8, 
159.2, 152.7, 148.5, 137.9, 134.9, 134.4, 128.9, 127.4, 125.4, 124.6, 121.2, 108.2, 108.0, 
102.1, 44.2.  IR(KBr) cm-1 3099, 3069, 2929, 1741, 1688, 1616, 1505, 1451, 1340, 1265, 
1184. 
 
2-(2-oxo-2-(pyridin-3-yl)ethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3u) 
N
O
O
N
S
O O
 
Reaction of 3-(1-((trimethylsilyl)oxy)vinyl)pyridine according to the general procedure 
afforded 36 mg (48%) of product after column chromatography using silica gel (1:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 206.5-207.2 oC; 1H NMR (CDCl3): δ 
9.25 (s 1H), 8.88-8.87 (d 1H), 8.31-8.29 (d 1H), 8.14-8.12 (d 1H), 7.99-7.98 (d 1H), 7.94-
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7.87 (2t 2H), 7.52-7.49 (t 1H), 5.15 (s 2H); 13C NMR (CDCl3): δ 188.1, 159.1, 154.6, 
149.4 137.9, 135.6, 135.1, 134.6, 129.8, 127.2, 125.6, 124.0, 121.3, 44.4.  IR(KBr) cm-1 
3095, 3078, 2965, 2927, 1737, 1709, 1589, 1464, 1418, 1332, 1317, 1234, 1182; HRMS 
(ESI): calcd for C14H10N2NaO4S (M+ Na+): 325.0259, found: 325.0251. 
 
2-(2-(furan-2-yl)-2-oxoethyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3v)26 
O
O
O
N
S
O O  
Reaction of ((1-(furan-2-yl)vinyl)oxy)trimethylsilane according to the general procedure 
afforded 52 mg (71%) of product after column chromatography using alumina gel (1:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 181.3-182.4 oC; 1H NMR (CDCl3): δ 
8.12-10 (d 1H), 7.97-7.95 (d 1H), 7.92-7.85 (2t 2H), 7.66 (d 1H), 7.36-7.35 (d 1H), 6.63-
6.62 (t 1H), 5.03 (s 2H); 13C NMR (CDCl3): δ 178.4, 159.0, 150.7, 147.1, 137.9, 135.0, 
134.5, 127.3, 125.5, 121.2, 118.3, 112.8, 43.8; IR (KBr) cm-1 3124, 3097, 2968, 2934, 
1737, 1685, 1594, 1465, 1349, 1299, 1187, 1045. 
 
2-(2-oxocyclopentyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3w)26 
O
N
S
O O
O
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Reaction of (cyclopent-1-en-1-yloxy)trimethylsilane according to the general procedure 
afforded 22 mg (33%) of product after column chromatography using silica gel (2:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 165.3-166.0 oC; 1H NMR (CDCl3): δ 
8.03-8.02 (d 1H), 7.93-7.91 (d 1H), 7.89-7.82 (2t 2H), 4.38-4.34 (dd 1H), 2.56-2.44 (m 
4H), 2.31-2.25(m 1H), 1.99-1.88 (m 1H); 13C NMR (CDCl3): δ 209.5, 158.2, 137.8, 
134.9, 134.5, 127.1, 125.3, 121.1, 56.3, 35.6, 26.7, 19.1;  IR (KBr) cm-1 3095, 3073, 
2961, 2897, 1756, 1732, 465, 1456, 1333, 1313, 1187. 
 
2-(2-oxocyclohexyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3x)26 
O O
N
S
O O  
Reaction of (cyclohex-1-en-1-yloxy)trimethylsilane according to the general procedure 
afforded 13 mg (18%) of product after column chromatography using silica gel (2:1 
hexanes/ethyl acetate). Isolated as a white solid; mp 183.7-184.7 oC; 1H NMR (CDCl3): δ 
8.06-8.04 (d 1H), 7.91-7.81 (d 1H, 2t 2H), 4.67-4.63 (dd 1H), 2.70-2.67 (td 1H), 2.65-
2.59 (td 1H), 2.55-2.51 (m 1H), 2.47-2.40 (td 1H), 2.17-2.12 (m 2H). 1.88-1.80 (qtd 2H); 
13C NMR (CDCl3): δ 200.2, 159.0, 137.8, 134.8, 134.3, 127.3, 125.3, 120.9, 60.0, 40.8, 
30.3, 25.9, 25.0; IR (KBr) cm-1 3099, 3030, 2950, 2927, 2901, 2866, 1740, 1718, 1355, 
1333, 1304, 1180. 
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